Expression of B7 Family Co-inhibitory Molecules in the Establishment of Pulmonary Regional Immunity
Abstract
To identify the temporal-spatial expression of B7 family co-inhibitory molecules during lung development, and to explore the roles of B7 family co-inhibitory molecules in the developmental process of pulmonary regional immunity. Methods The expression of B7 family co-inhibitory molecules (B7-1, B7-2, B7-H1, B7-DC） in different developmental stages of Rhesus monkey lungs were normalized and calculated by the reads per kilo-base of transcript per million mapped reads (RPKM) method. Immunohistochemical staining was performed to identify the localization and the protein of B7 family co-inhibitory molecules in different developmental phase (canalicular stage, cystic stage, alveolar stage) in mouse. Results The expression of B7 family co-inhibitory molecules in rhesus monkey were increased during the prenatal period (cystic stage, alveolar stage), the expressions of B7-2 and B7-H1 mRNA were significantly increased in alveolar stage (P<0.05). The results of immuno-histochemistry indicated that B7 family co-inhibitory molecules were mainly expressed in airway epithelial cells, and their protein levels were increased during the prenatal period. The expressions of B7-2, B7-H1 and B7-DC were significantly increased from canalicular stage (P<0.05). The protein of B7-2 was higher in airway than that in bronchus (P<0.05).Conclusion B7 family co-inhibitory molecules are mainly expressed in airway epithelial cells, and the expressions are increased during the prenatal period, which suggests that B7 family co-inhibitory molecules are involved possibly in the development of pulmonary regional immunity.
Keywords: B7 family co-inhibitory molecules, Pulmonary regional immunity, The prenatal period
Full Text:
PDFReferences
GULHANI, BOZKAYA G, BILGIR F, et al. Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure; a prospective controlled study. Gynecol Endocrinol ,2011 ,27(8):568-571.
SHAHZAD K.HAI A, Ahmed A, et al. A Structured-based model for the decreased activity of Ala222Val and Glu429Ala methylenetetrahydrofolate reductase ( MTHFR ) mutants. Bioinformation,2013,9(18) : 929-936.
BOTTO LD, YANG Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol,2000,151(9):862-77.
OGINO S, WILSON RB. Genotype and haplotype distributions of MTHFR677C > T and 1298A > С single nucleotide polymorphisms; a meta-analysis. J Hum Genet, 2003,48(1): 1-7.
HARTL D, TIROUVANZIAM R, LAVAL J, et al. Innate immunity of the lung:from basic mechanisms to translational medicine. J Innate Immun. 2018[2018-08-16]. https://doi. org/10. 1159/000487057.
NEWTON AH, CARDANI A. BRACIALE TJ. The host immune response in respiratory virus infection; balancing virus clearance and immunopathology. Semin Immunopathol. 2016,38(4);471-482.
XU Y, WANG Y, BESNARD V, et al. Transcriptional programs controlling perinatal lung maturation. PLoS One, 2012,7(8) ;e37046[2018-08-16]. https://doi.org/10. 1371/ journal, pone. 0037046.
YU X, FENG L, HAN Z, et al. Crosstalk of dynamic functional modules in lung development of rhesus macaques. Mol Biosyst,2016,12(4): 1342-1349.
GOLLWITZER ES. SAGLANI S, TROMPETTE A, et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med,2014,20(6) ;642-647.
CEERAZ S, NOWAK EC, NOELLE RJ. B7 family checkpoint regulators in immune regulation and disease. Trends Immunol,2013,34(11): 556-563.
LEUNG J, SUH WK. The CD28-B7 family in anti-tumor immunity; emerging concepts in cancer immunotherapy. Immune Network,2014 ,14(6) ;265-276.
RACKLEY CR.STRIPP BR. Building and maintaining the epithelium of the lung. J Clin Invest, 2012, 122 ( 8): 2724- 2730.
BOUR-JORDAN H, ESENSTEN JH, MARTINEZ- LLORDELLA M, et al. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev,2011,241 (1); 180-205.
SCHILDBERG FA, KLEIN SR, FREEMAN GJ, et al. Coinhibitory pathways in the B7-CD28 ligand-receptor family. Immunity,2016,44(5) :955-972.
GOLLWITZER ES. MARSLAND BJ. Impact of early-life exposures on immune maturation and susceptibility to disease. Trends Immunol ,2015 ,36(11); 684-696.
PARRY RV, CHEMNITZ JM, FRAUWIRTH KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol,2005,25(21) :9543-9553.
TL W.DJ L,CY В» elal. CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1994, 1 ( 5 ): 405- 413.
PATSOUKIS N, BROWN J, PETKOVA V, et al. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci Signal, 2012,5(230) :ra46 [2018-08-16] . http://stke. sciencemag. org/content/5/230/ra46. doi; 10.1126/scisignal. 2002796.
KANEKO Y, KUWANO K. HAGIMOTO N, et al. Expression of B7-1, B7-2, and interleukin 12 in bleomycin- induced pneumopathy in mice. Int Arch Allergy Immunol, 1998,116(4):306-312.
TSUDA M,MATSUMOTO K.INOUE H. et al. Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA. Biochem Biophys Res Commun,2005, 330(1):263-270.
ESPINOSA V,RIVERA A. First line of defense:innate cell- mediated control of pulmonary aspergillosis. Front Microbiol,2016, 7; 272 [2018-08-16] . https://doi. org/10. 3389/fmicb. 2016.00272.
Refbacks
- There are currently no refbacks.
